F04 - DCES & Nutritional Counseling Roles in Metabolic Dysfunction Associated Fatty Liver Disease

Friday, August 8, 2025

10:30 AM – 11:15 AM MT

CE/CME Hours: .75 CE

Pharmacology Hours: .25 CE

Primary Presenter(s)

Melissa Magwire, MSN, RN, CDCES

Program Director
Cardiometabolic Center Alliance
Kansas City, Kansas

Disclosure(s): Boehringer Ingelheim: Consultant / Advisory Board (Ongoing); Novo Nordisk: Consultant / Advisory Board (Ongoing)

Co-Presenter(s)

Susan Juechter, MS, RDN, CDN, CDCES

Senior Clinical Dietitian
Northwell Health
SLEEPY HOLLOW, New York

Disclosure(s): No financial relationships to disclose

MASH/MASLD is a cardiovascular risk equivalent often accompanied by obesity-related conditions such as diabetes and is estimated to affect up to 38% of adults worldwide. DCES stand to make a significant impact on the prevention and management of these conditions by applying their knowledge of risk factors, lifestyle and nutritional modifications, and current therapeutic guidelines when working as a member of collaborative care teams.

Disclosure(s):

Melissa Magwire, MSN, RN, CDCES: Boehringer Ingelheim: Consultant / Advisory Board (Ongoing); Novo Nordisk: Consultant / Advisory Board (Ongoing)

Susan Juechter, MS, RDN, CDN, CDCES: No financial relationships to disclose